📣 VC round data is live. Check it out!

111 Valuation Multiples

Discover revenue and EBITDA valuation multiples for 111 and similar public comparables like SOFTMAX, Mister Spex, Beforepay, Deepnoid and more.

111 Overview

About 111

111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People’s Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.


Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

111 Financials

111 reported last fiscal year revenue of $2B and EBITDA of $4M.

In the same fiscal year, 111 generated $106M in gross profit, $4M in EBITDA, and had net loss of ($10M).


111 P&L

In the most recent fiscal year, 111 reported revenue of $2B and EBITDA of $4M.

111 is unprofitable as of last fiscal year, with gross margin of 6%, EBITDA margin of 0%, and net margin of (1%).

See analyst estimates for 111
Last FY202320242025202620272028
Revenue$2B$2B$2B$2B
Gross Profit$106M$125M$122M$106M
Gross Margin6%6%6%6%
EBITDA$4M($46M)$4M$4M
EBITDA Margin0%(2%)0%0%
EBIT Margin(0%)(2%)0%(0%)
Net Profit($10M)($58M)($10M)($10M)
Net Margin(1%)(3%)(0%)(1%)

Financial data powered by Morningstar, Inc.

111 Stock Performance

111 has current market cap of $53M, and enterprise value of $6M.


111's stock price is $6.05.

111 has an EPS (earnings per share) of $-1.11.

See more trading valuation data for 111
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$6M$53M0.0%$-1.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

111 Valuation Multiples

111 trades at 0.0x EV/Revenue multiple, and 1.5x EV/EBITDA.

See NTM and 2027E valuation multiples for 111

111 Financial Valuation Multiples

As of May 10, 2026, 111 has market cap of $53M and EV of $6M.

111 has a P/E ratio of (5.5x).

Last FY202320242025202620272028
EV/Revenue0.0x0.0x0.0x0.0x
EV/EBITDA1.5x(0.1x)1.6x1.5x
EV/EBIT(16.1x)(0.1x)18.1x(16.1x)
EV/Gross Profit0.1x0.0x0.0x0.1x
P/E(5.5x)(0.9x)(5.6x)(5.5x)
EV/FCF0.3x(0.1x)0.2x0.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified 111 Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

111 Margins & Growth Rates

In the most recent fiscal year, 111 reported gross margin of 6%, EBITDA margin of 0%, and net margin of (1%).

See estimated margins and future growth rates for 111

111 Margins

Last FY20242025202720282029
Gross Margin6%6%6%
EBITDA Margin0%0%0%
EBIT Margin(0%)0%(0%)
Net Margin(1%)(0%)(1%)
FCF Margin1%2%1%

111 Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(4%)(13%)
Gross Profit Growth(2%)(13%)
EBITDA Growth(108%)1%
EBIT Growth(101%)(212%)
Net Profit Growth(84%)3%
FCF Growth(154%)(54%)

Data powered by FactSet, Inc. and Morningstar, Inc.

111 Operational KPIs

111's revenue per employee in the last FY averaged $1.5M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for 111
Last FY202320242025202620272028
Revenue per Employee$1.5M
Opex per Employee$0.1M
S&M Expenses to Revenue2%3%2%2%
G&A Expenses to Revenue1%1%0%1%
Opex to Revenue6%8%6%6%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
SOFTMAX1.1x1.1x9.1x
Mister Spex0.2x0.2x(1.5x)(6.8x)
Beforepay2.4x2.1x8.6x7.7x
Deepnoid8.3x(6.5x)
BIT Computer1.4x4.9x
PharmX Technologies10.0x52.8x
Autopedia0.6x5.5x
Niyogin Fintech2.5x(62.5x)

This data is available for Pro users. Sign up to see all 111 competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About 111

When was 111 founded?111 was founded in 2013.
Where is 111 headquartered?111 is headquartered in China.
How many employees does 111 have?As of today, 111 has over 1K employees.
Is 111 publicly listed?Yes, 111 is a public company listed on Nasdaq.
What is the stock symbol of 111?111 trades under YI ticker.
When did 111 go public?111 went public in 2018.
Who are competitors of 111?111 main competitors include SOFTMAX, Mister Spex, Beforepay, Deepnoid, BIT Computer, PharmX Technologies, Autopedia, Niyogin Fintech, MeVis, LendInvest.
What is the current market cap of 111?111's current market cap is $53M.
What is the current revenue of 111?111's last fiscal year revenue is $2B.
What is the current EV/Revenue multiple of 111?Current revenue multiple of 111 is 0.0x.
Is 111 profitable?No, 111 is not profitable.
How many companies 111 has acquired to date?111 hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies 111 has invested to date?111 hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to 111

Lists including 111

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial